Abstract
Sepsis often leads to cardiac dysfunction and inflammation. This study investigated the clinical value of microRNA-328 (miR-328) in sepsis and its role in cardiac dysfunction and inflammation caused by sepsis. The expression level of miR-328 in the serum of the subjects was detected by qRT-PCR. Receiver operating characteristic (ROC) curve measured the diagnostic value of miR-328 in sepsis. Rat sepsis model was established to detect left ventricular systolic pressure (LVSP), left ventricular end-diastolic pressure (LVEDP), and maximal rate of increase/decrease of left ventricular pressure (±dp/dtmax). Myocardial injury markers serum cardiac troponin I (cTnI), myocardial kinase isoenzyme (CK-MB), and inflammatory factors were detected by enzyme-linked immunosorbent assay (ELISA). miR-328 expression was assessed in serum of sepsis patients and in rat models of sepsis. The AUC of ROC curve was 0.926, sensitivity 87.60%, and specificity 86.36%. Compared with the sham group, LVSP and +dp/dtmax were decreased in the rat model of sepsis. LVEDP, -dp/dtmax, cTnI, CK-MB, tumor necrosis factor-α, interleukin (IL)-6, and IL-1β were upregulated in the rat model of sepsis. The low expression of miR-328 reversed these indicators. miR-328 is a diagnostic marker for patients with sepsis, and decreasing the expression level of miR-328 can ameliorate cardiac dysfunction and cardiac inflammation in sepsis.
Highlights
Sepsis has been identified as a systemic inflammatory response to infection or injury [1]
There was no significant difference in age (Po0.150), gender (Po0.768), and BMI (Po0.258) between the healthy control group and the sepsis patients group, but significant differences in Scr, WBC, C-reactive protein (CRP), and PTC were observed (Po0.001)
The experimental results showed that the expression level of miR-328 was significantly positively correlated with the condition of sepsis (Table 2)
Summary
Sepsis has been identified as a systemic inflammatory response to infection or injury [1]. About 50% of sepsis patients require intensive care unit treatment [2,3], leading to high morbidity and mortality [4,5]. Cardiac dysfunction is one of the common complications of sepsis-induced death [8,9]. Myocardial injury and myocardial depression are the most common cardiac dysfunctions caused by sepsis [10]. As a systemic inflammatory response, inflammation-related serum C-reactive protein (CRP), procalcitonin (PTC), and interleukin (IL-6) have been used in the diagnosis of sepsis [12,13], but their specificity and sensitivity are limited by different conditions. New biomarkers are urgently needed for the early diagnosis and accurate assessment of sepsis patients
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have